All

A Report of the American College of Cardiology Foundation/American Heart Association/ American College of Physicians Task Force on Competence and Training (Writing Committee to Develop a Competence and Training Statement on Prevention of Cardiovascular Disease) Developed in Collaboration With the... more

0
No votes yet

.field.field-name-field-embargo.field-type-datetime.field-label-hidden, .field.field-name-field-rating.field-type-fivestar.field-label-inline.clearfix, .links { display: none } .body_table li, .head_table li, .body_table p, .head_table p { line-height: 20px; } .body_table a, .... more

0
No votes yet

The Journal of Clinical Lipidology announced on Monday its 2016 Impact Factor has risen to 5.812, up from 4.906 in 2015.

Abstract: The first efforts to uncover the causes of cardiovascular disease focused on the behavioral, now called lifestyle habits of populations. Diet, exercise, and smoking were recognized as important issues with strong relationships in community-based observational studies such as the Seven... more

0
No votes yet

The National Lipid Association (NLA) today announced the publication of a new meta-analysis evaluating the impact of low-density lipoprotein cholesterol (LDL-C) lowering on major adverse cardiovascular events (MACE) in primary prevention populations. The study synthesizes data from randomized... more

A greater prevalence of dyslipidemia, insulin resistance, and atherosclerotic cardiovascular disease (ASCVD) and related-mortality are now well-recognized in South Asians living in the U.S. (SAUS), a fast-growing group that includes individuals from India, Pakistan, Bangladesh, Sri Lanka, Nepal,... more

0
No votes yet

The NLA is currently accepting nominations for Officer and At-Large positions for the NLA Board of Directors and all Chapter Boards of Directors. To submit an NLA or Chapter Board nomination, click here. All nominations are due on March 03, 2017.  

The National Lipid Association has been quite busy since the 2018 Scientific Sessions in Las Vegas.

The National Lipid Association's campaign for National Cholesterol Education Month is a social-media focused initiative to raise awareness about the importance of cholesterol management and its impact on cardiovascular health. Throughout September, the NLA will lead a social media campaign... more

Multiple randomized controlled trials have demonstrated significant reductions in major cardiovascular (CV) events and mortality with statin therapy.(1) These data have supported the “LDL-C treatment strategy,” in which CV event risk reduction is directly proportionate to the extent of... more

0
No votes yet